Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
17,797
archived clinical trials in
Peripheral Vascular Disease

Coronary Flow Reserve Following Orbital Atherectomy
Coronary Flow Reserve Following Orbital Atherectomy and Percutaneous Revascularization in Severely Calcified Coronary Lesions
Status: Enrolling
Updated:  8/10/2016
Mercy Hospital
mi
from
Coon Rapids, MN
Coronary Flow Reserve Following Orbital Atherectomy
Coronary Flow Reserve Following Orbital Atherectomy and Percutaneous Revascularization in Severely Calcified Coronary Lesions
Status: Enrolling
Updated: 8/10/2016
Mercy Hospital
mi
from
Coon Rapids, MN
Click here to add this to my saved trials
Coronary Flow Reserve Following Orbital Atherectomy
Coronary Flow Reserve Following Orbital Atherectomy and Percutaneous Revascularization in Severely Calcified Coronary Lesions
Status: Enrolling
Updated:  8/10/2016
St. Francis Hospital
mi
from
Roslyn, NY
Coronary Flow Reserve Following Orbital Atherectomy
Coronary Flow Reserve Following Orbital Atherectomy and Percutaneous Revascularization in Severely Calcified Coronary Lesions
Status: Enrolling
Updated: 8/10/2016
St. Francis Hospital
mi
from
Roslyn, NY
Click here to add this to my saved trials
An Intervention to Reduce Delirium After Cardiac Surgery
An Intervention to Reduce Delirium After Cardiac Surgery
Status: Enrolling
Updated:  8/10/2016
Johns Hopkins Hospital
mi
from
Baltimore, MD
An Intervention to Reduce Delirium After Cardiac Surgery
An Intervention to Reduce Delirium After Cardiac Surgery
Status: Enrolling
Updated: 8/10/2016
Johns Hopkins Hospital
mi
from
Baltimore, MD
Click here to add this to my saved trials
Evaluating CVD Medication Adherence Program in Low SES
Evaluating CVD Medication Adherence Program in Low SES
Status: Enrolling
Updated:  8/11/2016
Duke University Health System Clinic
mi
from
Durham, NC
Evaluating CVD Medication Adherence Program in Low SES
Evaluating CVD Medication Adherence Program in Low SES
Status: Enrolling
Updated: 8/11/2016
Duke University Health System Clinic
mi
from
Durham, NC
Click here to add this to my saved trials
Saving Life and Limb: FES for the Elderly With PAD
Saving Life and Limb: Functional Electrical Stimulation for the Elderly With Peripheral Artery Disease
Status: Enrolling
Updated:  8/15/2016
MultiCare Tacoma General Hospital
mi
from
Tacoma, WA
Saving Life and Limb: FES for the Elderly With PAD
Saving Life and Limb: Functional Electrical Stimulation for the Elderly With Peripheral Artery Disease
Status: Enrolling
Updated: 8/15/2016
MultiCare Tacoma General Hospital
mi
from
Tacoma, WA
Click here to add this to my saved trials
Prospective, Single Blind, Rand Controlled Study to Evaluate the Safety & Effectness of Tryton Side Branch Stent Used With DES Treatmt of de Novo Bifurcation Lesions in MB & SB in Native Coronaries
TRYTON PIVOTAL IDE Coronary Bifurcation Extended Access Study
Status: Enrolling
Updated:  10/17/2016
Jeffery Moses
mi
from
New York City, NY
Prospective, Single Blind, Rand Controlled Study to Evaluate the Safety & Effectness of Tryton Side Branch Stent Used With DES Treatmt of de Novo Bifurcation Lesions in MB & SB in Native Coronaries
TRYTON PIVOTAL IDE Coronary Bifurcation Extended Access Study
Status: Enrolling
Updated: 10/17/2016
Jeffery Moses
mi
from
New York City, NY
Click here to add this to my saved trials
Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Grafting (CABG) Involving Cardiopulmonary Bypass
Randomized, Multicenter, Placebo-Controlled, Double-Blind, Parallel Group Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Graft Surgery Involving Cardiopulmonary Bypass
Status: Enrolling
Updated:  11/17/2016
Baptist Medical Center - Princeton
mi
from
Birmingham, AL
Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Grafting (CABG) Involving Cardiopulmonary Bypass
Randomized, Multicenter, Placebo-Controlled, Double-Blind, Parallel Group Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Graft Surgery Involving Cardiopulmonary Bypass
Status: Enrolling
Updated: 11/17/2016
Baptist Medical Center - Princeton
mi
from
Birmingham, AL
Click here to add this to my saved trials
Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Grafting (CABG) Involving Cardiopulmonary Bypass
Randomized, Multicenter, Placebo-Controlled, Double-Blind, Parallel Group Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Graft Surgery Involving Cardiopulmonary Bypass
Status: Enrolling
Updated:  11/17/2016
Cardiology PC
mi
from
Birmingham, AL
Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Grafting (CABG) Involving Cardiopulmonary Bypass
Randomized, Multicenter, Placebo-Controlled, Double-Blind, Parallel Group Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Graft Surgery Involving Cardiopulmonary Bypass
Status: Enrolling
Updated: 11/17/2016
Cardiology PC
mi
from
Birmingham, AL
Click here to add this to my saved trials
Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Grafting (CABG) Involving Cardiopulmonary Bypass
Randomized, Multicenter, Placebo-Controlled, Double-Blind, Parallel Group Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Graft Surgery Involving Cardiopulmonary Bypass
Status: Enrolling
Updated:  11/17/2016
Sharp Memorial Hospital
mi
from
San Diego, CA
Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Grafting (CABG) Involving Cardiopulmonary Bypass
Randomized, Multicenter, Placebo-Controlled, Double-Blind, Parallel Group Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Graft Surgery Involving Cardiopulmonary Bypass
Status: Enrolling
Updated: 11/17/2016
Sharp Memorial Hospital
mi
from
San Diego, CA
Click here to add this to my saved trials
Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Grafting (CABG) Involving Cardiopulmonary Bypass
Randomized, Multicenter, Placebo-Controlled, Double-Blind, Parallel Group Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Graft Surgery Involving Cardiopulmonary Bypass
Status: Enrolling
Updated:  11/17/2016
Memorial Medical Center
mi
from
Springfield, IL
Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Grafting (CABG) Involving Cardiopulmonary Bypass
Randomized, Multicenter, Placebo-Controlled, Double-Blind, Parallel Group Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Graft Surgery Involving Cardiopulmonary Bypass
Status: Enrolling
Updated: 11/17/2016
Memorial Medical Center
mi
from
Springfield, IL
Click here to add this to my saved trials
Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Grafting (CABG) Involving Cardiopulmonary Bypass
Randomized, Multicenter, Placebo-Controlled, Double-Blind, Parallel Group Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Graft Surgery Involving Cardiopulmonary Bypass
Status: Enrolling
Updated:  11/17/2016
St. Johns Hospital
mi
from
Springfield, IL
Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Grafting (CABG) Involving Cardiopulmonary Bypass
Randomized, Multicenter, Placebo-Controlled, Double-Blind, Parallel Group Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Graft Surgery Involving Cardiopulmonary Bypass
Status: Enrolling
Updated: 11/17/2016
St. Johns Hospital
mi
from
Springfield, IL
Click here to add this to my saved trials
Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Grafting (CABG) Involving Cardiopulmonary Bypass
Randomized, Multicenter, Placebo-Controlled, Double-Blind, Parallel Group Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Graft Surgery Involving Cardiopulmonary Bypass
Status: Enrolling
Updated:  11/17/2016
Southern Illinois University School of Medicine
mi
from
Springfield, IL
Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Grafting (CABG) Involving Cardiopulmonary Bypass
Randomized, Multicenter, Placebo-Controlled, Double-Blind, Parallel Group Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Graft Surgery Involving Cardiopulmonary Bypass
Status: Enrolling
Updated: 11/17/2016
Southern Illinois University School of Medicine
mi
from
Springfield, IL
Click here to add this to my saved trials
Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Grafting (CABG) Involving Cardiopulmonary Bypass
Randomized, Multicenter, Placebo-Controlled, Double-Blind, Parallel Group Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Graft Surgery Involving Cardiopulmonary Bypass
Status: Enrolling
Updated:  11/17/2016
Lutheran Hospital of Indiana
mi
from
Fort Wayne, IN
Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Grafting (CABG) Involving Cardiopulmonary Bypass
Randomized, Multicenter, Placebo-Controlled, Double-Blind, Parallel Group Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Graft Surgery Involving Cardiopulmonary Bypass
Status: Enrolling
Updated: 11/17/2016
Lutheran Hospital of Indiana
mi
from
Fort Wayne, IN
Click here to add this to my saved trials
Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Grafting (CABG) Involving Cardiopulmonary Bypass
Randomized, Multicenter, Placebo-Controlled, Double-Blind, Parallel Group Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Graft Surgery Involving Cardiopulmonary Bypass
Status: Enrolling
Updated:  11/17/2016
Veterans Affairs Medical Center
mi
from
Lexington, KY
Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Grafting (CABG) Involving Cardiopulmonary Bypass
Randomized, Multicenter, Placebo-Controlled, Double-Blind, Parallel Group Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Graft Surgery Involving Cardiopulmonary Bypass
Status: Enrolling
Updated: 11/17/2016
Veterans Affairs Medical Center
mi
from
Lexington, KY
Click here to add this to my saved trials
Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Grafting (CABG) Involving Cardiopulmonary Bypass
Randomized, Multicenter, Placebo-Controlled, Double-Blind, Parallel Group Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Graft Surgery Involving Cardiopulmonary Bypass
Status: Enrolling
Updated:  11/17/2016
University of Kentucky Chandler Medical Center
mi
from
Lexington, KY
Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Grafting (CABG) Involving Cardiopulmonary Bypass
Randomized, Multicenter, Placebo-Controlled, Double-Blind, Parallel Group Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Graft Surgery Involving Cardiopulmonary Bypass
Status: Enrolling
Updated: 11/17/2016
University of Kentucky Chandler Medical Center
mi
from
Lexington, KY
Click here to add this to my saved trials
Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Grafting (CABG) Involving Cardiopulmonary Bypass
Randomized, Multicenter, Placebo-Controlled, Double-Blind, Parallel Group Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Graft Surgery Involving Cardiopulmonary Bypass
Status: Enrolling
Updated:  11/17/2016
St. Mary's of Michigan
mi
from
Saginaw, MI
Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Grafting (CABG) Involving Cardiopulmonary Bypass
Randomized, Multicenter, Placebo-Controlled, Double-Blind, Parallel Group Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Graft Surgery Involving Cardiopulmonary Bypass
Status: Enrolling
Updated: 11/17/2016
St. Mary's of Michigan
mi
from
Saginaw, MI
Click here to add this to my saved trials
Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Grafting (CABG) Involving Cardiopulmonary Bypass
Randomized, Multicenter, Placebo-Controlled, Double-Blind, Parallel Group Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Graft Surgery Involving Cardiopulmonary Bypass
Status: Enrolling
Updated:  11/17/2016
Covenant Medical Center
mi
from
Saginaw, MI
Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Grafting (CABG) Involving Cardiopulmonary Bypass
Randomized, Multicenter, Placebo-Controlled, Double-Blind, Parallel Group Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Graft Surgery Involving Cardiopulmonary Bypass
Status: Enrolling
Updated: 11/17/2016
Covenant Medical Center
mi
from
Saginaw, MI
Click here to add this to my saved trials
Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Grafting (CABG) Involving Cardiopulmonary Bypass
Randomized, Multicenter, Placebo-Controlled, Double-Blind, Parallel Group Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Graft Surgery Involving Cardiopulmonary Bypass
Status: Enrolling
Updated:  11/17/2016
Viahealth Rochester General Hospital
mi
from
Rochester, NY
Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Grafting (CABG) Involving Cardiopulmonary Bypass
Randomized, Multicenter, Placebo-Controlled, Double-Blind, Parallel Group Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Graft Surgery Involving Cardiopulmonary Bypass
Status: Enrolling
Updated: 11/17/2016
Viahealth Rochester General Hospital
mi
from
Rochester, NY
Click here to add this to my saved trials
Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Grafting (CABG) Involving Cardiopulmonary Bypass
Randomized, Multicenter, Placebo-Controlled, Double-Blind, Parallel Group Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Graft Surgery Involving Cardiopulmonary Bypass
Status: Enrolling
Updated:  11/17/2016
Duke Univ Med Ctr
mi
from
Durham, NC
Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Grafting (CABG) Involving Cardiopulmonary Bypass
Randomized, Multicenter, Placebo-Controlled, Double-Blind, Parallel Group Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Graft Surgery Involving Cardiopulmonary Bypass
Status: Enrolling
Updated: 11/17/2016
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Grafting (CABG) Involving Cardiopulmonary Bypass
Randomized, Multicenter, Placebo-Controlled, Double-Blind, Parallel Group Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Graft Surgery Involving Cardiopulmonary Bypass
Status: Enrolling
Updated:  11/17/2016
Brody School of Medicine at East Carolina University
mi
from
Greenville, NC
Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Grafting (CABG) Involving Cardiopulmonary Bypass
Randomized, Multicenter, Placebo-Controlled, Double-Blind, Parallel Group Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Graft Surgery Involving Cardiopulmonary Bypass
Status: Enrolling
Updated: 11/17/2016
Brody School of Medicine at East Carolina University
mi
from
Greenville, NC
Click here to add this to my saved trials
Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Grafting (CABG) Involving Cardiopulmonary Bypass
Randomized, Multicenter, Placebo-Controlled, Double-Blind, Parallel Group Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Graft Surgery Involving Cardiopulmonary Bypass
Status: Enrolling
Updated:  11/17/2016
Cardiac, Vascular, & Thoracic Surgeons, Inc.
mi
from
Cincinnati, OH
Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Grafting (CABG) Involving Cardiopulmonary Bypass
Randomized, Multicenter, Placebo-Controlled, Double-Blind, Parallel Group Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Graft Surgery Involving Cardiopulmonary Bypass
Status: Enrolling
Updated: 11/17/2016
Cardiac, Vascular, & Thoracic Surgeons, Inc.
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Grafting (CABG) Involving Cardiopulmonary Bypass
Randomized, Multicenter, Placebo-Controlled, Double-Blind, Parallel Group Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Graft Surgery Involving Cardiopulmonary Bypass
Status: Enrolling
Updated:  11/17/2016
Good Samaritan Hospital
mi
from
Cincinnati, OH
Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Grafting (CABG) Involving Cardiopulmonary Bypass
Randomized, Multicenter, Placebo-Controlled, Double-Blind, Parallel Group Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Graft Surgery Involving Cardiopulmonary Bypass
Status: Enrolling
Updated: 11/17/2016
Good Samaritan Hospital
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Grafting (CABG) Involving Cardiopulmonary Bypass
Randomized, Multicenter, Placebo-Controlled, Double-Blind, Parallel Group Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Graft Surgery Involving Cardiopulmonary Bypass
Status: Enrolling
Updated:  11/17/2016
Bethesda North Hospital
mi
from
Cincinnati, OH
Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Grafting (CABG) Involving Cardiopulmonary Bypass
Randomized, Multicenter, Placebo-Controlled, Double-Blind, Parallel Group Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Graft Surgery Involving Cardiopulmonary Bypass
Status: Enrolling
Updated: 11/17/2016
Bethesda North Hospital
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Grafting (CABG) Involving Cardiopulmonary Bypass
Randomized, Multicenter, Placebo-Controlled, Double-Blind, Parallel Group Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Graft Surgery Involving Cardiopulmonary Bypass
Status: Enrolling
Updated:  11/17/2016
Oklahoma Cardiovascular Associates
mi
from
Oklahoma City, OK
Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Grafting (CABG) Involving Cardiopulmonary Bypass
Randomized, Multicenter, Placebo-Controlled, Double-Blind, Parallel Group Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Graft Surgery Involving Cardiopulmonary Bypass
Status: Enrolling
Updated: 11/17/2016
Oklahoma Cardiovascular Associates
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Grafting (CABG) Involving Cardiopulmonary Bypass
Randomized, Multicenter, Placebo-Controlled, Double-Blind, Parallel Group Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Graft Surgery Involving Cardiopulmonary Bypass
Status: Enrolling
Updated:  11/17/2016
Oklahoma Cardiovascular Research Group
mi
from
Oklahoma City, OK
Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Grafting (CABG) Involving Cardiopulmonary Bypass
Randomized, Multicenter, Placebo-Controlled, Double-Blind, Parallel Group Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Graft Surgery Involving Cardiopulmonary Bypass
Status: Enrolling
Updated: 11/17/2016
Oklahoma Cardiovascular Research Group
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Grafting (CABG) Involving Cardiopulmonary Bypass
Randomized, Multicenter, Placebo-Controlled, Double-Blind, Parallel Group Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Graft Surgery Involving Cardiopulmonary Bypass
Status: Enrolling
Updated:  11/17/2016
Oklahoma Heart Hospital
mi
from
Oklahoma City, OK
Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Grafting (CABG) Involving Cardiopulmonary Bypass
Randomized, Multicenter, Placebo-Controlled, Double-Blind, Parallel Group Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Graft Surgery Involving Cardiopulmonary Bypass
Status: Enrolling
Updated: 11/17/2016
Oklahoma Heart Hospital
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Grafting (CABG) Involving Cardiopulmonary Bypass
Randomized, Multicenter, Placebo-Controlled, Double-Blind, Parallel Group Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Graft Surgery Involving Cardiopulmonary Bypass
Status: Enrolling
Updated:  11/17/2016
CardioThoracic Surgery Center, PLC
mi
from
Jackson, TN
Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Grafting (CABG) Involving Cardiopulmonary Bypass
Randomized, Multicenter, Placebo-Controlled, Double-Blind, Parallel Group Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Graft Surgery Involving Cardiopulmonary Bypass
Status: Enrolling
Updated: 11/17/2016
CardioThoracic Surgery Center, PLC
mi
from
Jackson, TN
Click here to add this to my saved trials
Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Grafting (CABG) Involving Cardiopulmonary Bypass
Randomized, Multicenter, Placebo-Controlled, Double-Blind, Parallel Group Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Graft Surgery Involving Cardiopulmonary Bypass
Status: Enrolling
Updated:  11/17/2016
Jackson Madison County General Hospital
mi
from
Jackson, TN
Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Grafting (CABG) Involving Cardiopulmonary Bypass
Randomized, Multicenter, Placebo-Controlled, Double-Blind, Parallel Group Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Graft Surgery Involving Cardiopulmonary Bypass
Status: Enrolling
Updated: 11/17/2016
Jackson Madison County General Hospital
mi
from
Jackson, TN
Click here to add this to my saved trials
Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Grafting (CABG) Involving Cardiopulmonary Bypass
Randomized, Multicenter, Placebo-Controlled, Double-Blind, Parallel Group Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Graft Surgery Involving Cardiopulmonary Bypass
Status: Enrolling
Updated:  11/17/2016
Centennial Medical Center
mi
from
Nashville, TN
Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Grafting (CABG) Involving Cardiopulmonary Bypass
Randomized, Multicenter, Placebo-Controlled, Double-Blind, Parallel Group Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Graft Surgery Involving Cardiopulmonary Bypass
Status: Enrolling
Updated: 11/17/2016
Centennial Medical Center
mi
from
Nashville, TN
Click here to add this to my saved trials
Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Grafting (CABG) Involving Cardiopulmonary Bypass
Randomized, Multicenter, Placebo-Controlled, Double-Blind, Parallel Group Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Graft Surgery Involving Cardiopulmonary Bypass
Status: Enrolling
Updated:  11/17/2016
Methodist Hospital
mi
from
Houston, TX
Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Grafting (CABG) Involving Cardiopulmonary Bypass
Randomized, Multicenter, Placebo-Controlled, Double-Blind, Parallel Group Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Graft Surgery Involving Cardiopulmonary Bypass
Status: Enrolling
Updated: 11/17/2016
Methodist Hospital
mi
from
Houston, TX
Click here to add this to my saved trials
Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Grafting (CABG) Involving Cardiopulmonary Bypass
Randomized, Multicenter, Placebo-Controlled, Double-Blind, Parallel Group Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Graft Surgery Involving Cardiopulmonary Bypass
Status: Enrolling
Updated:  11/17/2016
Winchester Medical Center
mi
from
Winchester, VA
Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Grafting (CABG) Involving Cardiopulmonary Bypass
Randomized, Multicenter, Placebo-Controlled, Double-Blind, Parallel Group Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Graft Surgery Involving Cardiopulmonary Bypass
Status: Enrolling
Updated: 11/17/2016
Winchester Medical Center
mi
from
Winchester, VA
Click here to add this to my saved trials
Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Grafting (CABG) Involving Cardiopulmonary Bypass
Randomized, Multicenter, Placebo-Controlled, Double-Blind, Parallel Group Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Graft Surgery Involving Cardiopulmonary Bypass
Status: Enrolling
Updated:  11/17/2016
FHS Research Center, St. Joseph Medical Center
mi
from
Tacoma, WA
Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Grafting (CABG) Involving Cardiopulmonary Bypass
Randomized, Multicenter, Placebo-Controlled, Double-Blind, Parallel Group Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Graft Surgery Involving Cardiopulmonary Bypass
Status: Enrolling
Updated: 11/17/2016
FHS Research Center, St. Joseph Medical Center
mi
from
Tacoma, WA
Click here to add this to my saved trials
Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Grafting (CABG) Involving Cardiopulmonary Bypass
Randomized, Multicenter, Placebo-Controlled, Double-Blind, Parallel Group Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Graft Surgery Involving Cardiopulmonary Bypass
Status: Enrolling
Updated:  11/17/2016
Northwest Cardiovascular Associates
mi
from
Tacoma, WA
Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Grafting (CABG) Involving Cardiopulmonary Bypass
Randomized, Multicenter, Placebo-Controlled, Double-Blind, Parallel Group Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Graft Surgery Involving Cardiopulmonary Bypass
Status: Enrolling
Updated: 11/17/2016
Northwest Cardiovascular Associates
mi
from
Tacoma, WA
Click here to add this to my saved trials
Action to Control Cardiovascular Risk in Diabetes (ACCORD)
Action to Control Cardiovascular Risk in Diabetes (ACCORD)
Status: Enrolling
Updated:  11/21/2016
Minneapolis Medical Research Foundation
mi
from
Minneapolis, MN
Action to Control Cardiovascular Risk in Diabetes (ACCORD)
Action to Control Cardiovascular Risk in Diabetes (ACCORD)
Status: Enrolling
Updated: 11/21/2016
Minneapolis Medical Research Foundation
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Action to Control Cardiovascular Risk in Diabetes (ACCORD)
Action to Control Cardiovascular Risk in Diabetes (ACCORD)
Status: Enrolling
Updated:  11/21/2016
Columbia University
mi
from
New York, NY
Action to Control Cardiovascular Risk in Diabetes (ACCORD)
Action to Control Cardiovascular Risk in Diabetes (ACCORD)
Status: Enrolling
Updated: 11/21/2016
Columbia University
mi
from
New York, NY
Click here to add this to my saved trials
Action to Control Cardiovascular Risk in Diabetes (ACCORD)
Action to Control Cardiovascular Risk in Diabetes (ACCORD)
Status: Enrolling
Updated:  11/21/2016
Wake Forest University
mi
from
Winston-Salem, NC
Action to Control Cardiovascular Risk in Diabetes (ACCORD)
Action to Control Cardiovascular Risk in Diabetes (ACCORD)
Status: Enrolling
Updated: 11/21/2016
Wake Forest University
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Action to Control Cardiovascular Risk in Diabetes (ACCORD)
Action to Control Cardiovascular Risk in Diabetes (ACCORD)
Status: Enrolling
Updated:  11/21/2016
Case Western Reserve Univ
mi
from
Cleveland, OH
Action to Control Cardiovascular Risk in Diabetes (ACCORD)
Action to Control Cardiovascular Risk in Diabetes (ACCORD)
Status: Enrolling
Updated: 11/21/2016
Case Western Reserve Univ
mi
from
Cleveland, OH
Click here to add this to my saved trials
Action to Control Cardiovascular Risk in Diabetes (ACCORD)
Action to Control Cardiovascular Risk in Diabetes (ACCORD)
Status: Enrolling
Updated:  11/21/2016
Veterans Affairs
mi
from
Memphis, TN
Action to Control Cardiovascular Risk in Diabetes (ACCORD)
Action to Control Cardiovascular Risk in Diabetes (ACCORD)
Status: Enrolling
Updated: 11/21/2016
Veterans Affairs
mi
from
Memphis, TN
Click here to add this to my saved trials
Action to Control Cardiovascular Risk in Diabetes (ACCORD)
Action to Control Cardiovascular Risk in Diabetes (ACCORD)
Status: Enrolling
Updated:  11/21/2016
Univ of Washington
mi
from
Seattle, WA
Action to Control Cardiovascular Risk in Diabetes (ACCORD)
Action to Control Cardiovascular Risk in Diabetes (ACCORD)
Status: Enrolling
Updated: 11/21/2016
Univ of Washington
mi
from
Seattle, WA
Click here to add this to my saved trials
Action to Control Cardiovascular Risk in Diabetes (ACCORD)
Action to Control Cardiovascular Risk in Diabetes (ACCORD)
Status: Enrolling
Updated:  11/21/2016
McMaster University
mi
from
Hamilton,
Action to Control Cardiovascular Risk in Diabetes (ACCORD)
Action to Control Cardiovascular Risk in Diabetes (ACCORD)
Status: Enrolling
Updated: 11/21/2016
McMaster University
mi
from
Hamilton,
Click here to add this to my saved trials
Mood and Nutrition Interventions in Polycystic Ovary Syndrome
Improving Psychological Health and Cardiovascular Disease Risk in Women With PCOS
Status: Enrolling
Updated:  11/22/2016
Penn PCOS Center
mi
from
Philadelphia, PA
Mood and Nutrition Interventions in Polycystic Ovary Syndrome
Improving Psychological Health and Cardiovascular Disease Risk in Women With PCOS
Status: Enrolling
Updated: 11/22/2016
Penn PCOS Center
mi
from
Philadelphia, PA
Click here to add this to my saved trials
The Use of Aging Biomarkers to Predict Adverse Outcomes After Cardiac Surgery
Status: Enrolling
Updated:  11/22/2016
Duke University
mi
from
Durham, NC
The Use of Aging Biomarkers to Predict Adverse Outcomes After Cardiac Surgery
Status: Enrolling
Updated: 11/22/2016
Duke University
mi
from
Durham, NC
Click here to add this to my saved trials
Study to Evaluate Darapladib in Moderately Hepatically Impaired Subjects
An Open-Label, Non-Randomized, Pharmacokinetic and Safety Study of Multiple Oral Doses of SB-480848 in Healthy Subjects and Subjects With Moderate Hepatic Impairment
Status: Enrolling
Updated:  11/30/2016
GSK Investigational Site
mi
from
Miami, FL
Study to Evaluate Darapladib in Moderately Hepatically Impaired Subjects
An Open-Label, Non-Randomized, Pharmacokinetic and Safety Study of Multiple Oral Doses of SB-480848 in Healthy Subjects and Subjects With Moderate Hepatic Impairment
Status: Enrolling
Updated: 11/30/2016
GSK Investigational Site
mi
from
Miami, FL
Click here to add this to my saved trials
Study to Evaluate Darapladib in Moderately Hepatically Impaired Subjects
An Open-Label, Non-Randomized, Pharmacokinetic and Safety Study of Multiple Oral Doses of SB-480848 in Healthy Subjects and Subjects With Moderate Hepatic Impairment
Status: Enrolling
Updated:  11/30/2016
GSK Investigational Site
mi
from
Orlando, FL
Study to Evaluate Darapladib in Moderately Hepatically Impaired Subjects
An Open-Label, Non-Randomized, Pharmacokinetic and Safety Study of Multiple Oral Doses of SB-480848 in Healthy Subjects and Subjects With Moderate Hepatic Impairment
Status: Enrolling
Updated: 11/30/2016
GSK Investigational Site
mi
from
Orlando, FL
Click here to add this to my saved trials
An Imaging Study in Patients With Atherosclerosis Taking Rilapladib or Placebo for 12 Weeks
A Multicenter, Randomized, 12 Week, Double-blind, Placebo-controlled, Parallel-group, Phase IIa Study Using 18F Fluorodeoxyglucose (FDG)-PET to Measure the Effects of Rilapladib on Macrophage Activity in Subjects With Atherosclerosis
Status: Enrolling
Updated:  11/30/2016
GSK Investigational Site
mi
from
Boston, MA
An Imaging Study in Patients With Atherosclerosis Taking Rilapladib or Placebo for 12 Weeks
A Multicenter, Randomized, 12 Week, Double-blind, Placebo-controlled, Parallel-group, Phase IIa Study Using 18F Fluorodeoxyglucose (FDG)-PET to Measure the Effects of Rilapladib on Macrophage Activity in Subjects With Atherosclerosis
Status: Enrolling
Updated: 11/30/2016
GSK Investigational Site
mi
from
Boston, MA
Click here to add this to my saved trials
An Imaging Study in Patients With Atherosclerosis Taking Rilapladib or Placebo for 12 Weeks
A Multicenter, Randomized, 12 Week, Double-blind, Placebo-controlled, Parallel-group, Phase IIa Study Using 18F Fluorodeoxyglucose (FDG)-PET to Measure the Effects of Rilapladib on Macrophage Activity in Subjects With Atherosclerosis
Status: Enrolling
Updated:  11/30/2016
GSK Investigational Site
mi
from
Brockton, MA
An Imaging Study in Patients With Atherosclerosis Taking Rilapladib or Placebo for 12 Weeks
A Multicenter, Randomized, 12 Week, Double-blind, Placebo-controlled, Parallel-group, Phase IIa Study Using 18F Fluorodeoxyglucose (FDG)-PET to Measure the Effects of Rilapladib on Macrophage Activity in Subjects With Atherosclerosis
Status: Enrolling
Updated: 11/30/2016
GSK Investigational Site
mi
from
Brockton, MA
Click here to add this to my saved trials
An Imaging Study in Patients With Atherosclerosis Taking Rilapladib or Placebo for 12 Weeks
A Multicenter, Randomized, 12 Week, Double-blind, Placebo-controlled, Parallel-group, Phase IIa Study Using 18F Fluorodeoxyglucose (FDG)-PET to Measure the Effects of Rilapladib on Macrophage Activity in Subjects With Atherosclerosis
Status: Enrolling
Updated:  11/30/2016
GSK Investigational Site
mi
from
Haverhill, MA
An Imaging Study in Patients With Atherosclerosis Taking Rilapladib or Placebo for 12 Weeks
A Multicenter, Randomized, 12 Week, Double-blind, Placebo-controlled, Parallel-group, Phase IIa Study Using 18F Fluorodeoxyglucose (FDG)-PET to Measure the Effects of Rilapladib on Macrophage Activity in Subjects With Atherosclerosis
Status: Enrolling
Updated: 11/30/2016
GSK Investigational Site
mi
from
Haverhill, MA
Click here to add this to my saved trials
An Imaging Study in Patients With Atherosclerosis Taking Rilapladib or Placebo for 12 Weeks
A Multicenter, Randomized, 12 Week, Double-blind, Placebo-controlled, Parallel-group, Phase IIa Study Using 18F Fluorodeoxyglucose (FDG)-PET to Measure the Effects of Rilapladib on Macrophage Activity in Subjects With Atherosclerosis
Status: Enrolling
Updated:  11/30/2016
GSK Investigational Site
mi
from
Linden, NJ
An Imaging Study in Patients With Atherosclerosis Taking Rilapladib or Placebo for 12 Weeks
A Multicenter, Randomized, 12 Week, Double-blind, Placebo-controlled, Parallel-group, Phase IIa Study Using 18F Fluorodeoxyglucose (FDG)-PET to Measure the Effects of Rilapladib on Macrophage Activity in Subjects With Atherosclerosis
Status: Enrolling
Updated: 11/30/2016
GSK Investigational Site
mi
from
Linden, NJ
Click here to add this to my saved trials
An Imaging Study in Patients With Atherosclerosis Taking Rilapladib or Placebo for 12 Weeks
A Multicenter, Randomized, 12 Week, Double-blind, Placebo-controlled, Parallel-group, Phase IIa Study Using 18F Fluorodeoxyglucose (FDG)-PET to Measure the Effects of Rilapladib on Macrophage Activity in Subjects With Atherosclerosis
Status: Enrolling
Updated:  11/30/2016
GSK Investigational Site
mi
from
New York, NY
An Imaging Study in Patients With Atherosclerosis Taking Rilapladib or Placebo for 12 Weeks
A Multicenter, Randomized, 12 Week, Double-blind, Placebo-controlled, Parallel-group, Phase IIa Study Using 18F Fluorodeoxyglucose (FDG)-PET to Measure the Effects of Rilapladib on Macrophage Activity in Subjects With Atherosclerosis
Status: Enrolling
Updated: 11/30/2016
GSK Investigational Site
mi
from
New York, NY
Click here to add this to my saved trials
An Imaging Study in Patients With Atherosclerosis Taking Rilapladib or Placebo for 12 Weeks
A Multicenter, Randomized, 12 Week, Double-blind, Placebo-controlled, Parallel-group, Phase IIa Study Using 18F Fluorodeoxyglucose (FDG)-PET to Measure the Effects of Rilapladib on Macrophage Activity in Subjects With Atherosclerosis
Status: Enrolling
Updated:  11/30/2016
GSK Investigational Site
mi
from
North Massapequa, NY
An Imaging Study in Patients With Atherosclerosis Taking Rilapladib or Placebo for 12 Weeks
A Multicenter, Randomized, 12 Week, Double-blind, Placebo-controlled, Parallel-group, Phase IIa Study Using 18F Fluorodeoxyglucose (FDG)-PET to Measure the Effects of Rilapladib on Macrophage Activity in Subjects With Atherosclerosis
Status: Enrolling
Updated: 11/30/2016
GSK Investigational Site
mi
from
North Massapequa, NY
Click here to add this to my saved trials